News Another Twitter blow to science as Musk ends COVID misinform... Twitter has announced that it has ceased enforcing its COVID-19 misinformation policy that prohibits misleading information about SARS-CoV-2.
News X4 Pharmaceuticals announces positive top-line results for W... X4 Pharmaceuticals has announced
News AstraZeneca leads winners at Reuters Pharma Awards 2022 On Thursday, 17 November, Reuters opened the doors for its first European awards ceremony.
Views & Analysis Increasing sustainability in pharma requires an industry-wid... With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to limit their environmental impact.
Partner Content Partner Content Illuminating Real-Time Patient Needs Through Socially Driven... Data collected via social health adds context, recency
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends